A 63-year-old Norwegian man has achieved long-term remission from HIV following a stem cell transplant, in a rare outcome that is drawing global scientific interest.

The man referred to as the “Oslo patient” underwent the procedure as part of treatment for a life-threatening blood disorder. He had been living with HIV since 2006 before being diagnosed in 2017 with myelodysplastic syndrome, a serious condition affecting the bone marrow.

Doctors opted for a stem cell transplant to treat the cancer, eventually selecting his older brother as the donor after failing to find a suitable match elsewhere. The procedure was not initially intended to target HIV, but it has since produced unexpected results.

After the transplant, the patient remained on antiretroviral therapy for some time before stopping treatment under strict medical supervision. Years later, there has been no detectable return of the virus, suggesting sustained remission.

Medical experts say the transplant replaced the patient’s immune system with one resistant to HIV. The donor carried a rare genetic mutation known as CCR5-delta-32, which blocks the virus from entering and infecting immune cells.

Researchers examining the case found no trace of the virus in the patient’s blood, gut, or bone marrow.

“We had no idea… That was amazing,” said Anders Eivind Myhre of Oslo University Hospital.

“For all practical purposes, we are quite certain that he is cured,” Myhre added.

The case joins a small number of similar instances worldwide where patients have achieved long-term HIV remission following stem cell transplants. However, scientists caution that such outcomes do not yet translate into a widely available cure.

Stem cell transplants are complex and high-risk procedures, typically reserved for patients with severe conditions like cancer. They can lead to serious complications, including infections and immune system rejection, making them unsuitable for the vast majority of people living with HIV.

Despite these limitations, researchers say such cases are crucial in advancing scientific understanding. Each successful outcome offers insights into how the virus can be controlled or potentially eliminated.

Efforts are now focused on developing safer and more accessible alternatives, including gene-editing technologies designed to replicate the protective effects of the CCR5 mutation without the need for transplants.

Globally, HIV remains a major public health challenge. While current treatments allow people to live long and healthy lives, they do not fully eliminate the virus, leaving scientists in continued search of a definitive cure.